Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients.
暂无分享,去创建一个
M. Matthay | C. Calfee | J. Stein | Brandon M. Imp | K. Kangelaris | J. Abbott | A. Cortez | J. Chu | Ashish Agrawal | Kathleen D. Liu
[1] Arthur S Slutsky,et al. Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .
[2] B. Thompson,et al. Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance* , 2012, Critical care medicine.
[3] Q. Shu,et al. Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children , 2012, Critical Care.
[4] M. Matthay,et al. Plasma Levels Of The Receptor For Advanced Glycation End Products (RAGE) Are Elevated In Early Acute Lung Injury But Not In Severe Sepsis , 2012, ATS 2012.
[5] Lung,et al. Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. , 2011, American journal of respiratory and critical care medicine.
[6] J. Zijlstra,et al. Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis. , 2011, Cytokine.
[7] L. Ware,et al. Biomarkers in acute lung injury--marking forward progress. , 2011, Critical care clinics.
[8] Ognjen Gajic,et al. Derivation and Diagnostic Accuracy of the Surgical Lung Injury Prediction Model , 2011, Anesthesiology.
[9] H. Hakonarson,et al. ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. , 2011, American journal of respiratory and critical care medicine.
[10] P. Parsons,et al. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury , 2011, Critical care medicine.
[11] Alison Fox-Robichaud,et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis* , 2011, Critical care medicine.
[12] Ognjen Gajic,et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. , 2011, American journal of respiratory and critical care medicine.
[13] M. Matthay,et al. Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients , 2010, Critical care medicine.
[14] V. Herasevich,et al. Acute lung injury prediction score: derivation and validation in a population-based sample , 2010, European Respiratory Journal.
[15] D. Needham,et al. Beyond mortality: future clinical research in acute lung injury. , 2010, American journal of respiratory and critical care medicine.
[16] Lesly A. Dossett,et al. Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. , 2010, The Journal of trauma.
[17] G. Bernard,et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. , 2010, Chest.
[18] S. Karumanchi,et al. Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium , 2009, Molecular and Cellular Biology.
[19] R. Balk. Positive End-Expiratory Pressure Setting in Adults With Acute Lung Injury and Acute Respiratory Distress Syndrome: A Randomized Controlled Trial , 2009 .
[20] P. Parsons,et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury , 2008, Thorax.
[21] V. V. van Hinsbergh,et al. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients , 2008, Thorax.
[22] M. Matthay,et al. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury , 2008, Critical care.
[23] Arthur S Slutsky,et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. , 2008, JAMA.
[24] S. Jaber,et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. , 2008, JAMA.
[25] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[26] D. Talmor,et al. CIRCULATING ANGIOPOIETIN 2 CORRELATES WITH MORTALITY IN A SURGICAL POPULATION WITH ACUTE LUNG INJURY/ADULT RESPIRATORY DISTRESS SYNDROME , 2007, Shock.
[27] A. Arroliga,et al. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[28] R. Homer,et al. Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death , 2006, Nature Medicine.
[29] Gordon R Bernard,et al. Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.
[30] M. Matthay,et al. Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury , 2006, Critical care.
[31] M. Matthay,et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. , 2006, American journal of respiratory and critical care medicine.
[32] D. Christiani,et al. Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans , 2006, PLoS medicine.
[33] G. Bernard,et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury* , 2005, Critical care medicine.
[34] Marek Ancukiewicz,et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. , 2009, The New England journal of medicine.
[35] P. Parsons,et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. , 2004, American journal of respiratory and critical care medicine.
[36] M. Matthay,et al. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury , 2001, Critical care medicine.
[37] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.
[38] Peggo K. W. Lam,et al. Derivation of a prediction rule for post-traumatic acute lung injury. , 1999, Resuscitation.
[39] P. Parsons,et al. Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. , 1996, Critical care medicine.
[40] M. Lamy,et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.
[41] Peter Harrison,et al. Platelet a-granules , 1993 .
[42] Paul J. Harrison,et al. Platelet alpha-granules. , 1993, Blood reviews.
[43] D. Green,et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. , 1990, The Journal of clinical investigation.